DK0941738T3 - Antigene konjugater af bevarede lipooligosaccharider af gramnegative bakterier - Google Patents

Antigene konjugater af bevarede lipooligosaccharider af gramnegative bakterier

Info

Publication number
DK0941738T3
DK0941738T3 DK99301747T DK99301747T DK0941738T3 DK 0941738 T3 DK0941738 T3 DK 0941738T3 DK 99301747 T DK99301747 T DK 99301747T DK 99301747 T DK99301747 T DK 99301747T DK 0941738 T3 DK0941738 T3 DK 0941738T3
Authority
DK
Denmark
Prior art keywords
negative bacteria
conserved
gram
lipooligosaccharides
lipopolysaccharide
Prior art date
Application number
DK99301747T
Other languages
Danish (da)
English (en)
Inventor
Rasappa G Arumugham
Maria Fortuna-Nevin
Michael A Apicella
Bradford W Gibson
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0941738(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0941738T3 publication Critical patent/DK0941738T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK99301747T 1998-03-10 1999-03-09 Antigene konjugater af bevarede lipooligosaccharider af gramnegative bakterier DK0941738T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3752998A 1998-03-10 1998-03-10
EP99301747A EP0941738B1 (fr) 1998-03-10 1999-03-09 Conjugués antigéniques de lipooligosaccharides de bactéries gram-négatives

Publications (1)

Publication Number Publication Date
DK0941738T3 true DK0941738T3 (da) 2005-08-08

Family

ID=21894823

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99301747T DK0941738T3 (da) 1998-03-10 1999-03-09 Antigene konjugater af bevarede lipooligosaccharider af gramnegative bakterier

Country Status (12)

Country Link
EP (1) EP0941738B1 (fr)
JP (1) JPH11322793A (fr)
KR (1) KR100628664B1 (fr)
AT (1) ATE295181T1 (fr)
AU (2) AU766184B2 (fr)
BR (1) BR9902008A (fr)
CA (1) CA2264970A1 (fr)
DE (1) DE69925187T2 (fr)
DK (1) DK0941738T3 (fr)
ES (1) ES2241240T3 (fr)
PT (1) PT941738E (fr)
SI (1) SI0941738T1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2364726A3 (fr) * 1999-09-30 2011-11-09 Isis Innovation Limited Vaccin contre l'infection Neisseria
US7749511B2 (en) 2000-04-18 2010-07-06 Endobiologics, Incorporated Anti-sepsis conjugate vaccine
CA2406229C (fr) 2000-04-18 2010-09-07 Endobiologics, Incorporated Vaccin conjugue anti-sepsie
US7364739B2 (en) 2000-08-25 2008-04-29 National Research Council Of Canada Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections
AU2000278267A1 (en) * 2000-09-01 2002-03-22 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
EP1374892A1 (fr) * 2002-06-28 2004-01-02 Braun, Jan Matthias, Dr. Médicament pour le traitement des maladies causées par une infection de neisseria meningitidis
EP1961427A3 (fr) 2002-08-02 2009-11-04 GlaxoSmithKline Biologicals S.A. Vaccin antineisseria comprenant une combinaison d'antigenes
WO2004043405A2 (fr) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Vaccin a base de polysaccharide destine a combattre les infections aux staphylocoques
EA012984B1 (ru) * 2003-12-17 2010-02-26 Вайет Конъюгаты иммуногенных пептидных носителей и способы их получения
MY144231A (en) 2003-12-17 2011-08-15 Wyeth Corp Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
BRPI0519923A8 (pt) 2004-12-17 2018-01-23 De Staat Der Nederlanden Vertegenwoordigd Door De Mini Van Vws polipeptídeo, seqüência de dna, vetor de dna, anticorpo, bactéria, método para produzir lps parcialmente 3-0-desacilado, composição, usos da bactéria, e de lps de bordetella isolado compreendendo lps pelo menos parcialmente 3-0-desacilado, vacina, e, método in vitro para a desacilação de lps gram-negativo ou de composições compreendendo lps gram-negativo, e, para induzir uma resposta imune contra bordetella.
KR20130122810A (ko) 2005-06-27 2013-11-08 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신 제조 방법
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
WO2007144316A2 (fr) 2006-06-12 2007-12-21 Glaxosmithkline Biologicals Sa Vaccin
WO2010011284A2 (fr) 2008-07-21 2010-01-28 The Brigham And Women's Hospital, Inc. Procédés et compositions se rapportant à des bêta-1,6-glucosamine oligosaccharides synthétiques
CA2761916A1 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Procede pour adjuver le lipopolysaccharide (lps) des bacteries a gram-negatif
AU2010247254A1 (en) 2009-05-14 2012-01-12 Sanofi Pasteur Menigococcus vaccine containing lipooligosaccharide (LOS) from modified strains of L6 immunotype Neisseria meningitidis
JP5536765B2 (ja) * 2009-05-20 2014-07-02 国立大学法人鳥取大学 部分糖鎖エピトープを用いた、病原性ナイセリア属細菌感染の検出方法およびそれら細菌に対するワクチン
CN102869378A (zh) 2010-03-10 2013-01-09 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
EP2575870B1 (fr) 2010-06-04 2016-12-07 Wyeth LLC Formulations vaccinales
PL404229A1 (pl) 2013-06-06 2014-12-08 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie
CN103308686B (zh) * 2013-06-28 2016-04-06 武汉云克隆科技股份有限公司 脂多糖酶联免疫吸附测定试剂盒的制备方法
KR101509456B1 (ko) * 2013-10-04 2015-04-14 아이진 주식회사 리포폴리사카라이드 유사체 및 이를 포함하는 면역보조 조성물
CN104352762A (zh) * 2014-12-11 2015-02-18 谭清平 一种用于治疗脓毒症的中药及其制备方法
CA3033364A1 (fr) 2016-09-02 2018-03-08 Sanofi Pasteur, Inc. Vaccin contre neisseria meningitidis
BR112019010227A2 (pt) * 2016-11-25 2019-10-08 Glaxosmithkline Biologicals Sa conjugado imunogênico, processo para preparação de conjugado imunogênico, composição imunogênica, vacina, e, uso de nomv
CN112125832B (zh) * 2020-08-12 2022-09-20 北京大学 刺突蛋白受体结合结构域纳米凝胶及其制备方法与应用
KR20240004299A (ko) * 2021-03-15 2024-01-11 그리피스 유니버시티 병원체 모이어티 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887483B2 (en) * 1995-12-01 2005-05-03 University Of Iowa Research Foundation Non-toxic mutants of pathogenic gram-negative bacteria

Also Published As

Publication number Publication date
DE69925187T2 (de) 2006-03-09
EP0941738B1 (fr) 2005-05-11
ES2241240T3 (es) 2005-10-16
DE69925187D1 (de) 2005-06-16
CA2264970A1 (fr) 1999-09-10
AU1954099A (en) 1999-09-23
KR19990077705A (ko) 1999-10-25
BR9902008A (pt) 2000-05-09
JPH11322793A (ja) 1999-11-24
AU2004200060B2 (en) 2005-10-13
AU2004200060A1 (en) 2004-01-29
PT941738E (pt) 2005-09-30
EP0941738A1 (fr) 1999-09-15
SI0941738T1 (en) 2005-10-31
AU766184B2 (en) 2003-10-09
ATE295181T1 (de) 2005-05-15
KR100628664B1 (ko) 2006-09-27

Similar Documents

Publication Publication Date Title
DK0941738T3 (da) Antigene konjugater af bevarede lipooligosaccharider af gramnegative bakterier
FI862370A (fi) Monoklonaalisia vasta-aineita syklosporiineille
ATE397456T1 (de) Enterokokkus antigene und vakzine
WO1998058668A3 (fr) VACCIN CONTENANT UN ANTIGENE DE $i(BORDETELLA PERTUSSIS)
NO902909D0 (no) T-celle-epitop som baerermolekyl for konjugat-vaksiner.
AU1248583A (en) Conjugates of muramyl-peptides and haptenes
ES553425A0 (es) Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
DK101196A (da) Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet
DE59707944D1 (de) Elektromotor
AU3841993A (en) Synthetic lipid a glycoconjugate antigens for use in vaccines